AdviseClinical was built with one goal in mind, to help our partners make better decisions faster. To do this, we offer our partners accomplished professionals dedicated throughout the life of a project. We are not a small CRO disguising ourselves as a large one similarly our customers are not small companies pretending to be large ones. We know to succeed in this marketplace, flexibility is critical and doing things differently is essential.

The market continues to evolve with a number of industry dynamics fueling demand for a new development model. The drug industry's productivity is falling, there is increased pressure on earnings, companies are downsizing, outsourcing has dramatically increased and venture capital funding is not as abundant as it once was. These dynamics are driving the change for a new CRO model, a model that creates more value in all facets of drug development, from advisory activity, risk sharing and a significant emphasis on specific capabilities as opposed to just scale.

AdviseClinical is just the right size to ensure you get the attention you deserve, the value needed for your investment and the experience that is required to deliver the service level that you demand. We know success will come from offering the most accomplished professionals the market has to offer, while maintaining flexibility and scalability.